Statistics for Serum proteomics signature of Cystic Fibrosis patients: A complementary 2-DE and LC–MS/MS approach
Total visits
| views | |
|---|---|
| Serum proteomics signature of Cystic Fibrosis patients: A complementary 2-DE and LC–MS/MS approach | 346 |
Total visits per month
| views | |
|---|---|
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 0 |
File Visits
| views | |
|---|---|
| Serum proteomics signature of Cystic Fibrosis patientsA complementary 2-DE and LC–MS-MS approach.pdf | 93 |
Top country views
| views | |
|---|---|
| United States | 206 |
| China | 35 |
| Portugal | 23 |
| United Kingdom | 21 |
| Germany | 17 |
| France | 9 |
| Russia | 7 |
| Netherlands | 5 |
| Poland | 4 |
| Iran | 3 |
| European Union | 2 |
| Turkey | 2 |
| Australia | 1 |
| Canada | 1 |
| Algeria | 1 |
| Spain | 1 |
| India | 1 |
| Italy | 1 |
| Jordan | 1 |
| Morocco | 1 |
| Mexico | 1 |
| Singapore | 1 |